Healthcare, Regulatory and Reimbursement Landscape - Singapore


March 31, 2012
156 Pages - SKU: GBDT3865605
License type:
Countries covered: Singapore

Healthcare, Regulatory and Reimbursement Landscape - Singapore

Summary

GlobalData, the industry analysis specialist, has released its report, “Healthcare, Regulatory and Reimbursement Landscape - Singapore”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Singapore. The report identifies the key trends in the healthcare market of Singapore. The report also provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Singapore. Most importantly, the report provides valuable insights on the trends and segmentation of pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape of Singapore. The scope includes -
  • Overview of the pharmaceutical and medical devices market of Singapore including the market size, market segmentation, key drivers and barriers for the market.
  • Profile and SWOT analysis of the major players in the pharmaceutical and medical devices market.
  • Insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, regulatory agencies and market authorization process for new drug and medical devices for Singapore.
  • A detailed analysis of the political and economic environment of Singapore including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
  • An overview of the opportunities and challenges for growth that exist in the healthcare market of Singapore.
Reasons to buy

The report on Singapore comprehensively covers both the pharmaceutical and the medical devices market of Singapore. The report will enhance your decision making capability. It will allow you to -
  • Develop business strategies by understanding the trends shaping and driving the healthcare market of Singapore.
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the Singapore healthcare market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • Identify, understand and capitalize on the opportunities and challenges in the healthcare market of Singapore.



More Healthcare reports by GlobalData

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US by GlobalData
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - USSummaryGlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US”. ...
Nuffield Health - Strategic SWOT Analysis Review by GlobalData
Nuffield Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a ...
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy by GlobalData
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - ItalySummaryGlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy”. ...
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France by GlobalData
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - FranceSummaryGlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France”. ...
See all reports like this >>

More Singapore Healthcare reports

Singapore Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Unlike other developed Asia Pacific countries, we note that the Singaporean government isseeking to increase its share of healthcare expenditure in light of ...
Singapore's Connected Healthcare Journey: An Update by IDC
Singapore's vision of "One Singaporean, One Health Record" is moving forward in its technological journey. Over the past few months, IDC Health Insights had several ...
Healthcare Building Construction in Singapore to 2016: Market Databook by Timetric
SynopsisTimetric’s 'Healthcare Building Construction in Singapore to 2016: Market Databook' contains detailed historic and forecast market value data for the healthcare buildings construction industry, including ...
Singapore Pharmaceuticals and Healthcare Report Q1 2013 by Business Monitor International
BMI View: Singapore will be of moderate attractiveness to investors given its small pharmaceuticalmarket size, despite the growing demands for more pharmaceuticals and healthcare from ...
See all reports like this >>

More Singapore reports

D&B Country RiskLine Report: Singapore by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
See all reports like this >>